T2 Biosystems to Report First Quarter 2021 Financial Results on May 6, 2021

Rhea-AI Summary

T2 Biosystems (NASDAQ:TTOO) will report its first quarter 2021 financial results after market close on May 6, 2021. A conference call will follow at 4:30 p.m. ET. T2 Biosystems specializes in the rapid detection of sepsis-causing pathogens, aiming to enhance patient care and reduce treatment costs. Their product lineup includes the T2Dx® Instrument and various diagnostic panels powered by proprietary T2 Magnetic Resonance technology. Interested parties can access the conference call via the company’s website or by phone.

Positive

• T2 Biosystems is positioned as a leader in rapid pathogen detection, potentially increasing demand for their products.
• The upcoming financial results report may provide insights on future growth and market position.

Negative

• None.

LEXINGTON, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the first quarter of 2021 after market close on Thursday, May 6, 2021. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.t2biosystems.com, on the Investors page in the Events & Presentations section. The call will also be available by dialing 1-800-496-4125 (U.S.) or 1-856-344-9209 (International) five to ten minutes prior to the start time.

About T2 Biosystems:
T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products include the T2Dx® Instrument, T2Candida® Panel, the T2Bacteria® Panel, the T2Resistance™ Panel, and the T2SARS-CoV-2™ Panel and are powered by the proprietary T2 Magnetic Resonance (T2MR®) technology. T2 Biosystems has an active pipeline of future products, including the T2Cauris™ Panel, and T2Lyme™ Panel, as well as additional products for the detection of bacterial and fungal pathogens and associated antimicrobial resistance markers, and biothreat pathogens.

Media Contact:
Gina Kent, Vault Communications
gkent@vaultcommunications.com 
610-455-2763

Investor Contact:
Philip Trip Taylor, Gilmartin Group
philip@gilmartinIR.com
415-937-5406

FAQ

When will T2 Biosystems report its Q1 2021 financial results?

T2 Biosystems will report its Q1 2021 financial results on May 6, 2021, after market close.

What time is the T2 Biosystems conference call?

The conference call will begin at 4:30 p.m. ET on May 6, 2021.

How can I listen to the T2 Biosystems conference call?

Investors can listen to the conference call via the company’s website or by dialing 1-800-496-4125 (U.S.) or 1-856-344-9209 (International).

What products does T2 Biosystems offer?

T2 Biosystems offers products such as the T2Dx® Instrument, T2Candida® Panel, T2Bacteria® Panel, and T2Resistance™ Panel, utilizing T2 Magnetic Resonance technology.